Search Results - "Papadimitropoulos, M."

impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study by Papaioannou, A, Kennedy, C. C, Ioannidis, G, Sawka, A, Hopman, W. M, Pickard, L, Brown, J. P, Josse, R. G, Kaiser, S, Anastassiades, T, Goltzman, D, Papadimitropoulos, M, Tenenhouse, A, Prior, J. C, Olszynski, W. P, Adachi, J. D

“…Summary Using prospective data from the Canadian Multicentre Osteoporosis Study (CaMos), we compared health utilities index (HUI) scores after 5 years of…”
Get full text

Are milk and alternatives and fruit and vegetable intakes during adolescence associated with cortical and trabecular bone structure, density, and strength in adulthood? by Z. Movassagh, E., Kontulainen, S., Baxter-Jones, A. D. G., Whiting, S., Szafron, M., Papadimitropoulos, M., Vatanparast, H.

“…Summary We investigated the impact of food group intake during adolescence on bone structure and strength during adulthood. In females, we found a beneficial…”
Get full text

Valuing Health in the Uae: An Investigation of the Feasibility and Cultural Appropriateness of Using the TTO and DCE Methods to Generate Health State Values by Papadimitropoulos, M, El Barazi, I, Blair, I, Kalsaiti, S, Shah, K, Devlin, N

Get full text

Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort Study by Yang, Y, Song, Y, Chen, W, Liu, W, Wang, K, Li, X, Papadimitropoulos, M, Montgomery, W

Get full text

PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan: The Road Ahead? by Mitchell, B, Curtis, B, Liu, L.L, Boye, K.S, Papadimitropoulos, M

Get full text

Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai by Yang, Y, Ye, W, Song, Y, Liu, W, Wang, K, Li, X, Papadimitropoulos, M, Montgomery, W

Get full text

PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study by Burge, R, Ionnadis, G, Adachi, J, Papadimitropoulos, M

Get full text

Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China by Guo, J.J, Liu, L, Du, W, Peng, H, Wang, R, Xin, P, Chen, Y, Wigle, P.R, Papadimitropoulos, M

Get full text

Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion by Varla-Leftherioti, M., Spyropoulou-Vlachou, M., Keramitsoglou, T., Papadimitropoulos, M., Tsekoura, C., Graphou, O., Papadopoulou, C., Gerondi, M., Stavropoulos-Giokas, C.

“…Previous studies have revealed that women with unexplained recurrent spontaneous abortions have a limited repertoire of inhibitory KI receptors (inhKIRs) and…”
Get full text

PND17 THE BURDEN OF MIGRAINE IN LATIN AMERICA by Papadimitropoulos, M., Ford, J., Sharma, I., Velez, K., L, Méndez

Get full text

PSY4 BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN COLOMBIA AND BRAZIL by Papadimitropoulos, M., Brnabic, A., Vorstenbosch, E., Prandi, B., Moyano, S.

Get full text

Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy by Brnabic, A, Xavier, R, Goncalves, L, Lucas, J, Hernandez, P, Gaich, CL, Papadimitropoulos, M

“…OBJECTIVES: To present demographics and characteristics of Latin American patients with rheumatoid arthritis (RA). METHODS: Data was collected in 2015 for the…”
Get full text

Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab by Burge, RT, Papadimitropoulos, M, Henneges, C, Garcia, EG, Romiti, R

“…OBJECTIVES: Ixekizumab (IXE) is a high-affinity monoclonal antibody that selectively targets interleukin-l7A and has demonstrated superiority to ustekinumab…”
Get full text

PSY7 - Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy by Brnabic, A, Xavier, R, Goncalves, L, Lucas, J, Hernandez, P, Gaich, CL, Papadimitropoulos, M

Get full text

PSY36 - Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab by Burge, RT, Papadimitropoulos, M, Henneges, C, Garcia, EG, Romiti, R

Get full text

PSS36 - Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America by Romiti, R, Papadimitropoulos, M, Lin, C, Burge, RT, Zhu, B, Garcia, EG

Get full text

Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab by Burge, RT, Papadimitropoulos, M, Henneges, C, Garcia, EG, Romiti, R

“…OBJECTIVES: Ixekizumab (IXE) is a high-affinity monoclonal antibody that selectively targets interleukin-17A and superiority to ustekinumab (UST) at 12 weeks…”
Get full text

Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America by Romiti, R, Papadimitropoulos, M, Lin, C, Burge, RT, Zhu, B, Garcia, EG

“…OBJECTIVES: Ixekizumab (IXE) is a high affinity anti-IL-17A antibody shown to be highly effective in reducing psoriasis plaques and improving health-related…”
Get full text

PSY37 - Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab by Burge, RT, Papadimitropoulos, M, Henneges, C, Garcia, EG, Romiti, R

Get full text

PSY6 - Treatment Patterns and Impact of Not Achieving Skin Clearance for Psoriasis Patients In Latin America by Papadimitropoulos, M, Romiti, R, Garcia, EG, Lobosco, S, Leonardi Reyes, F, Wang, X, Haynes, G

Get full text